Loading company…
PharmatrophiX, Inc., based in Raleigh, develops disease-modifying small-molecule drugs for neurodegenerative diseases.
Based in North Carolina, US, PharmatrophiX was founded in 2005 by founder Frank Longo and develops drugs for neurodegenerative diseases and other disorders. Its small-molecule drugs aim to slow or prevent disease progression by targeting underlying biological mechanisms, with a focus on synaptic resilience in the brain. The company uses a virtual business model. In October 2014, Dolby Family Ventures completed a USD 5.5 million Series A round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in